Current perspective of neuroprotection and glaucoma

Area of Science:

• Ophthalmology
• Neuroscience

Background:

• Glaucoma is a leading cause of blindness, characterized by optic nerve atrophy and retinal ganglion cell (RGC) loss.
• Elevated intraocular pressure (IOP) is a primary risk factor, but RGC loss can occur even with normal IOP.
• Current treatments primarily focus on reducing IOP, which may not fully address neurodegeneration.

Purpose of the Study:

• To review conventional glaucoma treatments.
• To discuss novel neuroprotective strategies for glaucoma.
• To highlight advances in noninvasive diagnostics for glaucoma management.

Main Methods:

• Review of preclinical data on neuroprotective therapies.
• Analysis of recent advancements in noninvasive diagnostic tools.
• Discussion of therapeutic strategies targeting RGCs and optic nerve damage.

Main Results:

• Progress in developing neuroprotective therapies for glaucoma.
• Emerging noninvasive diagnostics offer a broader view beyond IOP.
• New strategies directly address RGC loss and optic nerve damage.

Conclusions:

• Neuroprotective therapies represent a promising frontier in glaucoma treatment.
• Advanced diagnostics enable earlier detection and monitoring.
• A paradigm shift towards neuroprotection offers potential for vision restoration and preservation.